We have previously reported that rats exposed chronically to citalopram are able to elicit a corticosterone but not adrenocorticotropic hormone (ACTH) response to restraint stress. Thus we proposed the hypothesis that the corticosterone response to restraint in citalopram-treated rats was maintained due to increased adrenal sensitivity to lower ACTH levels. To test this hypothesis, we intravenously injected ACTH (1—24) to rats (dose 3 ng/rat) exposed to citalopram through minipump infusion for 14 days and to control rats (no citalopram). ACTH significantly increased plasma corticosterone levels in both control and citalopram treated rats over a period of 120 min. There was no significant difference in plasma corticosterone between citalopram treated rats and control rats at any time point. Therefore we conclude that, under these experimental conditions, citalopram does not appear to sensitize the rodent adrenal gland to ACTH, and that other mechanisms may be responsible for the ACTH/corticosterone disconnection.
Bornstein S.R., Chrousos G.P. (1999) Adrenocorticotrophin (ACTH) - and non-ACTH-mediated regulation of the adrenal cortex: Neural and Immune imputs. J Clin Endocrinol Metab84: 1729—1736
2.
Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., Muglia L.J. (2005) Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behaviour . Proc Natl Acad Sci102: 473—478
3.
Dallman M.F., Akana S.F., Levin N., Walker C.D., Bradbury M.J., Suemaru S., Scribner K.S. (1994) Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann N Y Acad Sci746: 22—31
4.
Davis L., Yonkers K., Trivedi M., Kramer G., Petty F. (1999) The mechanism of action of SSRI's: a new hypothesis . In Stanford S C (ed.), Selective serotonin reuptake inhibitors: Past present and future. University College, London
5.
Harbuz M.S., Rees R.G., Eckland D., Jessop D.S., Brewerton D., Lightman S.L. (1992) Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology130: 1394—1400
6.
Harbuz M.S., Rooney C., Jones M. and Ingram C.D. (1994) Hypothalamo-pituitary-adrenal axis response to lipopolysaccharide in male and female rats with adjuvant-induced arthritis . Brain Behav Immun13: 335—347
7.
Hesketh S., Jessop D.S., Hogg S., Harbuz M.S. (2005) Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress. J Endocrinol185: 373—382
8.
Jacobson L., Sapolsky R. (1991) The role of the hippocampus in feedback regulation of hypothalamic-pituitary-adrenocortical axis. Endocr Rev12: 118—134
9.
Jensen J., Jessop D., Harbuz M., Mork A., Sanchez C., Mikkelsen J. (1999) Acute and long-term treatments with the selective serotonin inhibitor citalopram modulates the HPA axis activity at different levels in male rats. J Neuroendocrinol11: 465—471
10.
Jensen J., Mork A., Mikkelsen J. (2001) Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: Effects of acute stress and 5HT1A receptor activation. J Neuroendocrinol13: 887—893
11.
Larsen P.J., Mikkelsen J.D., Jessop D., Lightman S.L., Chowdrey H.S. (1994). Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axis. J Endocrinol141: 497—503
12.
Leggett J.D., Harbuz M.S., Jessop D.S., Fulford A.J. (2006). The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats. Neuroscience141: 2051—2057
13.
Maes M., Meltzer Y., D'Hondt P., Cosyns P., Blockx P. (1995) Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology20: 149—167
14.
Masand P., Gupta S. (1999) Selective serotonin reuptake inhibitors: An update . Harvard Rev Psychiatry7: 69—84
15.
Moncek F., Duncko R., Jezova D. (2003). Repeated citalopram treatment but not stress exposure attenuates hypothalamic-pituitary-adrenocortical axis response to acute citalopram injection. Life Sci72: 1353—1365
16.
Nemeroff C., Winderlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C., Loosen P., Vale W. ( 1984) Elevated concentration of CSF CRF immunoreactivity in depressed patients. Science226: 1342—1344
17.
Pariante C.M. (2004) Glucocorticoid receptor functions in vitro in patients with major depression. Stress7: 209—219
18.
Raap D., Van de Kar L (1999) Selective serotonin re-uptake inhibitors and neuroendocrine function. Life Sci65: 1217—1235
19.
Sage D., Maurel D., Bosler O. (2002) Corticosterone-dependent driving influence of the suprachiasmatic nucleus on adrenal sensitivity to ACTH. Am J Physiol Endocrinol Metab282: E458—E465
20.
Schinner S., Bornstein S.R. (2005) Cortical-chromaffin cell interactions in the adrenal gland. Endocr Pathol16: 91—98
21.
Schroeter S., Levey A I., Blakely R.D. (1997) Polarized expression of the antidepressant-sensitive serotonin transporter in epinephrine-synthesizing chromaffin cells of the rat adrenal gland. Mol Cel Neurosc9: 170—184
22.
Young E., Haskett R., Murphy-Weinberg V., Watson S., Akil H. ( 1991) Loss of fast-feedback in depression. Arch Gen Psychiatry48: 693—699
